共查询到20条相似文献,搜索用时 15 毫秒
1.
Aymen I. Idris Antonia Sophocleous Euphemie Landao-Bassonga Meritxell Canals Graeme Milligan David Baker Robert J. van't Hof Stuart H. Ralston 《Cell metabolism》2009,10(2):139-147
Age-related osteoporosis is characterized by reduced bone formation and accumulation of fat in the bone marrow compartment. Here, we report that the type 1 cannabinoid receptor (CB1) regulates this process. Mice with CB1 deficiency (CB1−/−) had increased peak bone mass due to reduced bone resorption, but developed age-related osteoporosis with reduced bone formation and accumulation of adipocytes in the bone marrow space. Marrow stromal cells from CB1−/− mice had an enhanced capacity for adipocyte differentiation, a reduced capacity for osteoblast differentiation, and increased expression of phosphorylated CREB (pCREB) and PPARγ. Pharmacological blockade of CB1 receptors stimulated adipocyte differentiation, inhibited osteoblast differentiation, and increased cAMP and pCREB in osteoblast and adipocyte precursors. The CB1 receptor is therefore unique in that it regulates peak bone mass through an effect on osteoclast activity, but protects against age-related bone loss by regulating adipocyte and osteoblast differentiation of bone marrow stromal cells. 相似文献
2.
3.
4.
Osteoblasts are mononucleated cells that are derived from mesenchymal stem cells and that are responsible for the synthesis
and mineralization of bone during initial bone formation and later bone remodelling. Osteoblasts also have a role in the regulation
of osteoclast activity through the receptor activator of nuclear factor κ-B ligand and osteoprotegerin. Abnormalities in osteoblast
differentiation and activity occur in some common human diseases such as osteoporosis and osteoarthritis. Recent studies also
suggest that osteoblast functions are compromised at sites of focal bone erosion in rheumatoid arthritis. 相似文献
5.
6.
影响骨髓间质干细胞向成骨细胞分化的调控因素 总被引:3,自引:0,他引:3
长期的骨骼废用引起的骨质减少主要归因于骨形成的减少,成骨细胞由具有多向分化潜能的间充质细胞经骨原细胞、前成骨细胞分化而来,骨髓间质干细胞是骨髓来源的具有多向分化潜能的干细胞,本文综述了骨髓间质干细胞向成骨细胞分化的调控因素,有助于增加对骨丢失的理解,并进行预防和治疗,为航天员和骨骼废用病人创造更健康的生活。 相似文献
7.
Marlène Gallet Soraya Sa?di Eric Ha? Johann Photsavang Caroline Marty Juliette Sailland Julie Carnesecchi Violaine Tribollet Bruno Barenton Christelle Forcet Marie-Christine Birling Tania Sorg Olivier Chassande Martine Cohen-Solal Jean-Marc Vanacker 《PloS one》2013,8(1)
ERRα is an orphan member of the nuclear receptor family, the complete inactivation of which confers resistance to bone loss induced by ageing and estrogen withdrawal to female mice in correlation with increased bone formation in vivo. Furthermore ERRα negatively regulates the commitment of mesenchymal cells to the osteoblast lineage ex vivo as well as later steps of osteoblast maturation. We searched to determine whether the activities of ERRα on osteoblast maturation are responsible for one or both types of in vivo induced bone loss. To this end we have generated conditional knock out mice in which the receptor is normally present during early osteoblast differentiation but inactivated upon osteoblast maturation. Bone ageing in these animals was similar to that observed for control animals. In contrast conditional ERRαKO mice were completely resistant to bone loss induced by ovariectomy. We conclude that the late (maturation), but not early (commitment), negative effects of ERRα on the osteoblast lineage contribute to the reduced bone mineral density observed upon estrogen deficiency. 相似文献
8.
Takashi Matsumoto Atsushi Yamada Ryo Aizawa Dai Suzuki Masayuki Tsukasaki Wataru Suzuki Mutsuko Nakayama Koutaro Maki Matsuo Yamamoto Kazuyoshi Baba Ryutaro Kamijo 《PloS one》2013,8(6)
Bone morphogenetic proteins (BMPs) regulate many aspects of skeletal development, including osteoblast and chondrocyte differentiation, cartilage and bone formation, and cranial and limb development. Among them, BMP-2, one of the most potent osteogenic signaling molecules, stimulates osteoblast differentiation, while it inhibits myogenic differentiation in C2C12 cells. To evaluate genes involved in BMP-2-induced osteoblast differentiation, we performed cDNA microarray analyses to compare BMP-2-treated and -untreated C2C12 cells. We focused on Alx3 (aristaless-like homeobox 3) which was clearly induced during osteoblast differentiation. Alx3, a homeobox gene related to the
Drosophila
aristaless
gene, has been linked to developmental functions in craniofacial structures and limb development. However, little is known about its direct relationship with bone formation. In the present study, we focused on the mechanisms of Alx3 gene expression and function during osteoblast differentiation induced by BMP-2. In C2C12 cells, BMP-2 induced increase of Alx3 gene expression in both time- and dose-dependent manners through the BMP receptors-mediated SMAD signaling pathway. In addition, silencing of Alx3 by siRNA inhibited osteoblast differentiation induced by BMP-2, as showed by the expressions of alkaline phosphatase (Alp), Osteocalcin, and Osterix, while over-expression of Alx3 enhanced osteoblast differentiation induced by BMP-2. These results indicate that Alx3 expression is enhanced by BMP-2 via the BMP receptors mediated-Smad signaling and that Alx3 is a positive regulator of osteoblast differentiation induced by BMP-2. 相似文献
9.
10.
Fromigué O Brun J Marty C Da Nascimento S Sonnet P Marie PJ 《Journal of cellular biochemistry》2012,113(9):3029-3038
Promoting osteoblastogenesis remains a major challenge in disorders characterized by defective bone formation. We recently showed that the alpha 5 integrin subunit (ITGA5) is critically involved in human mesenchymal cell osteoblast differentiation. In this study, we determined the potential of pharmacological ITGA5 activation by a synthetic cyclic peptide (GA-CRRETAWAC-GA) on murine osteoblast differentiation and function in vitro and bone formation in vivo. Peptide-mediated activation of ITGA5 in murine C3H10T1/2 mesenchymal cells resulted in the generation of the integrin-mediated cell signals FAK and ERK1/2-MAPKs. In vitro, peptide-based activation of ITGA5 protected from cell apoptosis but did not affect cell adhesion or replication, while it enhanced the expression of the osteoblast marker genes Runx2 and type I collagen and increased extracellular matrix (ECM) mineralization as also found with bone morphogenetic protein-2 (BMP2), a standard bone anabolic factor. When injected on adult mouse cranial bone for 3 weeks, the peptide-mediated activation of ITGA5 increased bone thickness by twofold, an effect also induced by BMP2. Histomorphometric analysis showed that this anabolic effect resulted from decreased cell apoptosis and increased bone forming surfaces and bone formation rate (BFR). We conclude that pharmacological activation of ITGA5 in mesenchymal cells is effective in promoting de novo bone formation as a result of increased osteoprogenitor cell differentiation into osteoblasts and increased cell protection from apoptosis. This peptide-based approach could be used therapeutically to promote the osteogenic capacity of osteoblast progenitor cells and to induce de novo bone formation in conditions where osteoblastogenesis is compromised. 相似文献
11.
12.
13.
14.
Emily Hays Jaime Schmidt Nalini Chandar 《In vitro cellular & developmental biology. Animal》2009,45(7):361-370
Selective knockdown of phosphatase and tensin homolog (PTEN) has been recently shown to increase life long accumulation of
bone and its ability to increase osteoblast lifespan. In order to determine how loss of PTEN function affects osteoblast differentiation,
we created cell lines with stable knockdown of PTEN expression using short hairpin RNA vectors and characterized several clones.
The effect of deregulated PTEN in osteoblasts was studied in relationship to cell proliferation and differentiation. Downregulation
of PTEN initially affected the cell’s attachment and spreading on plastic but cells recovered after a brief period of time.
When cell proliferation was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assays, we noticed
a small but significant increase in growth rates with PTEN reduction. The size of individual cells appeared larger when compared
to control cells. Differentiation properties of these osteoblasts were increased as evidenced by higher expression of several
of the bone markers tested (alkaline phosphatase, osteocalcin, osterix, bone morphogenetic protein 2, Cbfa1, osteoprotegerin,
and receptor activator of NF-kappaB ligand) and their mineralization capacity in culture. As stabilization of beta-catenin
is known to be responsible for growth deregulation with PTEN loss in other cell types, we investigated the activation of the
canonical Wnt pathway in our cell lines. Immunofluorescence staining, protein expression in subcellular fractions for beta-catenin,
and assays for activation of the canonical Wnt/beta-catenin signaling were studied in the PTEN downregulated cells. There
was an overall decrease in β-catenin expression in cells with PTEN knockdown. The distribution of β-catenin was more diffuse
within the cell in the PTEN-reduced clones when compared to controls where they were mostly present in cell borders. Signaling
through the canonical pathway was also reduced in the PTEN knockdown cells when compared to control. The results of this study
suggest that while decreased PTEN augments cell proliferation and positively affects differentiation, there is a decrease
in β-catenin levels and activity in osteoblasts. Therefore, at least in osteoblasts, β-catenin is not responsible for mediating
the activation of osteoblast differentiation with reduction in PTEN function. 相似文献
15.
Bin Zhu Feng Xue Changqing Zhang Guangyi Li 《Journal of cellular and molecular medicine》2019,23(8):5782-5793
Osteoporosis has become a worldwide problem as the population ages. Although many advances have been made in the treatment of osteoporosis in the past few years, the outcome are sometimes disturbing because of the adverse effects of these treatments. Further studies are still needed to identify novel alternate agents to improve the therapeutic effect. Ginkgolide B (GB), a derivative of Ginkgo biloba leaves, has numerous pharmacological effects, including anticancer and anti‐inflammation activities. However, the effect of GB on the regulation of osteoblast activity and bone formation effect has not yet been investigated. In this study, we showed the in vitro and in vivo effects of GB on osteoblast differentiation and bone formation. We found that GB promotes osteoblast differentiation of Bone Mesenchymal Stem Cells (BMSCs) and MC3T3‐E1 cells in vitro in a Wnt/β‐catenin‐dependent manner. In an in vivo study, we constructed a cranial defect model in rats and treated with GB. Histomorphometric and histological analyses confirmed that the usage of GB significantly promotes bone formation. Further study on ovariectomy (OVX) rats demonstrated that GB is capable of alleviating ovariectomy‐induced bone loss by enhancing osteoblast activity. Our findings indicate that GB is a potential therapeutic agent of osteoporosis through an anabolic way in bone. 相似文献
16.
17.
CCAAT/enhancer-binding protein homologous protein (CHOP) regulates osteoblast differentiation 总被引:4,自引:0,他引:4
下载免费PDF全文
![点击此处可从《Molecular and cellular biology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Shirakawa K Maeda S Gotoh T Hayashi M Shinomiya K Ehata S Nishimura R Mori M Onozaki K Hayashi H Uematsu S Akira S Ogata E Miyazono K Imamura T 《Molecular and cellular biology》2006,26(16):6105-6116
18.
Bone renews itself and changes shape throughout life to account for the changing needs of the body; this requires co-ordinated activities of bone resorbing cells (osteoclasts), bone forming cells (osteoblasts) and bone’s internal cellular network (osteocytes). This review focuses on paracrine signaling by the IL-6 family of cytokines between bone cells, bone marrow, and skeletal muscle in normal physiology and in pathological states where their levels may be locally or systemically elevated. These functions include the support of osteoclast formation by osteoblast lineage cells in response to interleukin 6 (IL-6), interleukin 11 (IL-11), oncostatin M (OSM) and cardiotrophin 1 (CT-1). In addition it will discuss how bone-resorbing osteoclasts promote osteoblast activity by secreting CT-1, which acts as a “coupling factor” on osteocytes, osteoblasts, and their precursors to promote bone formation. OSM, produced by osteoblast lineage cells and macrophages, stimulates bone formation via osteocytes. IL-6 family cytokines also mediate actions of other bone formation stimuli like parathyroid hormone (PTH) and mechanical loading. CT-1, OSM and LIF suppress marrow adipogenesis by shifting commitment of pluripotent precursors towards osteoblast differentiation. Ciliary neurotrophic factor (CNTF) is released as a myokine from skeletal muscle and suppresses osteoblast differentiation and bone formation on the periosteum (outer bone surface in apposition to muscle). Finally, IL-6 acts directly on marrow-derived osteoclasts to stimulate release of “osteotransmitters” that act through the cortical osteocyte network to stimulate bone formation on the periosteum. Each will be discussed as illustrations of how the extended family of IL-6 cytokines acts within the skeleton in physiology and may be altered in pathological conditions or by targeted therapies. 相似文献
19.
We investigated the in vitro and in vivo osteogenic activity of licochalcone A. At low concentrations, licochalcone A stimulated
the differentiation of mouse pre-osteoblastic MC3T3-E1 subclone 4 (MC4) cells and enhanced the bone morphogenetic protein
(BMP)-2-induced stimulation of mouse bi-potential mesenchymal precursor C2C12 cells to commit to the osteoblast differentiation
pathway. This osteogenic activity of licochalcone A was accompanied by the activation of extracellular-signal regulated kinase
(ERK). The involvement of ERK was confirmed in a pharmacologic inhibition study. Additionally, noggin (a BMP antagonist) inhibited
the osteogenic activity of licochalcone A in C2C12 cells. Licochalcone A also enhanced the BMP-2-stimulated expression of
various BMP mRNAs. This suggested that the osteogenic action of licochalcone A in C2C12 cells could be dependent on BMP signaling
and/or expression. We then tested the in vivo osteogenic activity of licochalcone A in two independent animal models. Licochalcone
A accelerated the rate of skeletal development in zebrafish and enhanced woven bone formation over the periosteum of mouse
calvarial bones. In summary, licochalcone A induced osteoblast differentiation with ERK activation in both MC4 and C2C12 cells
and it exhibited in vivo osteogenic activity in zebrafish skeletal development and mouse calvarial bone formation. The dual
action of licochalcone A in stimulating bone formation and inhibiting bone resorption, as described in a previous study, might
be beneficial in treating bone-related disorders. 相似文献